<html>

<head>
<meta http-equiv="Content-Type" content="text/html; charset=windows-1252">
<meta name="GENERATOR" content="Microsoft FrontPage 5.0">
<meta name="ProgId" content="FrontPage.Editor.Document">
<title>Norephinephrine</title>
<meta name="Microsoft Theme" content="neuro 011, default">
<meta name="Microsoft Border" content="l, default">
</head>

<body background="_themes/neuro/background.jpg" bgcolor="#FFFFFF" text="#003333" link="#669999" vlink="#3399CC" alink="#999999"><!--msnavigation--><table dir="ltr" border="0" cellpadding="0" cellspacing="0" width="100%"><tr><td valign="top" width="1%"><!--mstheme--><font face="Verdana, Arial, Helvetica">
<p>

<script language="JavaScript"><!--
MSFPhover = 
  (((navigator.appName == "Netscape") && 
  (parseInt(navigator.appVersion) >= 3 )) || 
  ((navigator.appName == "Microsoft Internet Explorer") && 
  (parseInt(navigator.appVersion) >= 4 ))); 
function MSFPpreload(img) 
{
  var a=new Image(); a.src=img; return a; 
}
// --></script><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav1n=MSFPpreload("_derived/home_cmp_neuro010_vbtn.gif"); MSFPnav1h=MSFPpreload("_derived/home_cmp_neuro010_vbtn_a.gif"); }
// --></script><a href="index.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav1'].src=MSFPnav1h.src" onmouseout="if(MSFPhover) document['MSFPnav1'].src=MSFPnav1n.src"><img src="_derived/home_cmp_neuro010_vbtn.gif" width="140" height="50" border="0" alt="--- HOME ---" name="MSFPnav1"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav2n=MSFPpreload("_derived/up_cmp_neuro010_vbtn.gif"); MSFPnav2h=MSFPpreload("_derived/up_cmp_neuro010_vbtn_a.gif"); }
// --></script><a href="treatment.drug.receptor.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav2'].src=MSFPnav2h.src" onmouseout="if(MSFPhover) document['MSFPnav2'].src=MSFPnav2n.src"><img src="_derived/up_cmp_neuro010_vbtn.gif" width="140" height="50" border="0" alt="&lt;&lt; BACK &lt;&lt;" name="MSFPnav2"></a></p>

<!--mstheme--></font></td><td valign="top" width="24"></td><!--msnavigation--><td valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica">

<h1 style="text-align:justify"><!--mstheme--><font color="#006666"><span style="mso-bidi-font-size: 10.0pt"><u>Norephinephrine
(NE)</u></span><!--mstheme--></font></h1>
<o:p>This neurotransmitter is associated with an increase in attention and 
vigilance. It is also known as noradrenalin, a close relative to adrenalin. It 
is good to think of norephinephrine as the neurotransmitter responsible for 
effects like the &quot;flight or fright&quot; response. This is when a scared individual's 
heart rate increases along with breathing. The muscles become activated and 
ready for action. One can see this is similar to the idea of vigilance and 
attention.<h3><!--mstheme--><font color="#006666">Alpha 1 receptor<!--mstheme--></font></h3>
<blockquote>
  <p>These receptors are located in the cerebral cortex, thalamus, hypothalamus 
  and the cerebellum. Binding in the cortex would greatly influence the positive 
  symptoms, as this area is the one responsible for things such as reason and 
  intellectuality. The hypothalamus is the main initiator of hormone secretion 
  from the pituitary gland thus, being a possible location from where hormone 
  levels can be altered. Hormone changes greatly affect one's mood and behavior. 
  The cerebellum is a part of motor control and may be involved in drug side 
  effects related to abnormal motor movements.</p>
</blockquote>
<h3><!--mstheme--><font color="#006666">Alpha 2 receptor<!--mstheme--></font></h3>
<blockquote>
  <p>These receptors are located in the caudate nucleus, putamen, the 
  hippocampus, the thalamus, the amygdala and the locus ceruleus. The caudate 
  and putamen are a part of the basal ganglia (the motor system within the 
  brain) and drug binding could contribute to motor side effects. </p>
  <p>The alpha receptor locations mentioned are those within the brain. There 
  are other areas where activation of these receptors could result in 
  constriction of blood vessels, and contraction of the spleen. These are other 
  effects of the &quot;flight or fright&quot; response. Due its role in the &quot;flight or 
  fright&quot; response, drug binding at these receptors may eventually result in 
  cardiovascular side effects.</p>
</blockquote>
<h3><!--mstheme--><font color="#006666">Norephinphrine reuptake receptor<!--mstheme--></font></h3>
<blockquote>
  <p>This is located where NE is released in many regions of the brain mentioned 
  above. It removes NE from the synapse (area of communication between neurons) 
  so that it can be recycled and used again. Due to the fact that antagonists at 
  this receptor would increase NE, it is doubtful that this may play a 
  significant role in relieving the schizophrenic symptoms.</p>
</blockquote>

<!--mstheme--></font><!--msnavigation--></td></tr><!--msnavigation--></table></body>

</html>